BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30021209)

  • 1. Fibroblast Growth Factor 9 Suppresses Striatal Cell Death Dominantly Through ERK Signaling in Huntington's Disease.
    Yusuf IO; Cheng PH; Chen HM; Chang YF; Chang CY; Yang HI; Lin CW; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Yang SH
    Cell Physiol Biochem; 2018; 48(2):605-617. PubMed ID: 30021209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF9 induces neurite outgrowth upon ERK signaling in knock-in striatal Huntington's disease cells.
    Yusuf IO; Chen HM; Cheng PH; Chang CY; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Chen CM; Yang SH
    Life Sci; 2021 Feb; 267():118952. PubMed ID: 33383048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 9 activates anti-oxidative functions of Nrf2 through ERK signalling in striatal cell models of Huntington's disease.
    Yusuf IO; Chen HM; Cheng PH; Chang CY; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Yang SH
    Free Radic Biol Med; 2019 Jan; 130():256-266. PubMed ID: 30391672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast Growth Factor 9 Stimulates Neuronal Length Through NF-kB Signaling in Striatal Cell Huntington's Disease Models.
    Yusuf IO; Chen HM; Cheng PH; Chang CY; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Chen CM; Yang SH
    Mol Neurobiol; 2021 May; 58(5):2396-2406. PubMed ID: 33421017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies.
    Brito V; Puigdellívol M; Giralt A; del Toro D; Alberch J; Ginés S
    Cell Death Dis; 2013 Apr; 4(4):e595. PubMed ID: 23598407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of BDNF and Full-Length TrkB Receptor Ameliorate Striatal Neural Survival in Huntington's Disease.
    Silva A; Naia L; Dominguez A; Ribeiro M; Rodrigues J; Vieira OV; Lessmann V; Rego AC
    Neurodegener Dis; 2015; 15(4):207-18. PubMed ID: 25896770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 9 activates akt and MAPK pathways to stimulate steroidogenesis in mouse leydig cells.
    Lai MS; Cheng YS; Chen PR; Tsai SJ; Huang BM
    PLoS One; 2014; 9(3):e90243. PubMed ID: 24603862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial-derived neurotrophic factor (GDNF) prevents ethanol (EtOH) induced B92 glial cell death by both PI3K/AKT and MEK/ERK signaling pathways.
    Villegas SN; Njaine B; Linden R; Carri NG
    Brain Res Bull; 2006 Dec; 71(1-3):116-26. PubMed ID: 17113937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF9-induced changes in cellular redox status and HO-1 upregulation are FGFR-dependent and proceed through both ERK and AKT to induce CREB and Nrf2 activation.
    Chuang JI; Huang JY; Tsai SJ; Sun HS; Yang SH; Chuang PC; Huang BM; Ching CH
    Free Radic Biol Med; 2015 Dec; 89():274-86. PubMed ID: 26424114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of phosphatidylinositol 3-kinase/Akt on basic fibroblast growth factor-induced glial cell line-derived neurotrophic factor release from rat glioma cells.
    Tanabe K; Matsushima-Nishiwaki R; Iida M; Kozawa O; Iida H
    Brain Res; 2012 Jun; 1463():21-9. PubMed ID: 22575563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of smad2 and Erk/Akt cascade in TGF-β1-induced apoptosis in human gingival epithelial cells.
    Yoshimoto T; Fujita T; Kajiya M; Matsuda S; Ouhara K; Shiba H; Kurihara H
    Cytokine; 2015 Sep; 75(1):165-73. PubMed ID: 25882870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
    Ripple MO; Kalmadi S; Eastman A
    Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of metabolism rescue cell death in Huntington's disease models.
    Varma H; Cheng R; Voisine C; Hart AC; Stockwell BR
    Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14525-30. PubMed ID: 17726098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the expression of extracellular regulated kinase (ERK 1/2) in the R6/2 mouse model of Huntington's disease after phosphodiesterase IV inhibition.
    Fusco FR; Anzilotti S; Giampà C; Dato C; Laurenti D; Leuti A; Colucci D'Amato L; Perrone L; Bernardi G; Melone MA
    Neurobiol Dis; 2012 Apr; 46(1):225-33. PubMed ID: 22311347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.
    Apostol BL; Simmons DA; Zuccato C; Illes K; Pallos J; Casale M; Conforti P; Ramos C; Roarke M; Kathuria S; Cattaneo E; Marsh JL; Thompson LM
    Mol Cell Neurosci; 2008 Sep; 39(1):8-20. PubMed ID: 18602275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 9 (FGF9) regulation of cyclin D1 and cyclin-dependent kinase-4 in ovarian granulosa and theca cells of cattle.
    Totty ML; Morrell BC; Spicer LJ
    Mol Cell Endocrinol; 2017 Jan; 440():25-33. PubMed ID: 27816766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p75 neurotrophin receptor augments survival signaling in the striatum of pre-symptomatic Q175(WT/HD) mice.
    Wehner AB; Milen AM; Albin RL; Pierchala BA
    Neuroscience; 2016 Jun; 324():297-306. PubMed ID: 26947127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK506 ameliorates cell death features in Huntington's disease striatal cell models.
    Rosenstock TR; de Brito OM; Lombardi V; Louros S; Ribeiro M; Almeida S; Ferreira IL; Oliveira CR; Rego AC
    Neurochem Int; 2011 Oct; 59(5):600-9. PubMed ID: 21703318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Activation Gi/o Protein Increases Glial Cell Line-Derived Neurotrophic Factor Production through Fibroblast Growth Factor Receptor and Extracellular Signal-Regulated Kinase Pathway in Primary Cultured Rat Cortical Astrocytes.
    Hisaoka-Nakashima K; Matsumoto C; Azuma H; Taki S; Takebayashi M; Nakata Y; Morioka N
    Biol Pharm Bull; 2017; 40(10):1759-1766. PubMed ID: 28966248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo.
    Du Y; Li X; Yang D; Zhang X; Chen S; Huang K; Le W
    Exp Biol Med (Maywood); 2008 Jul; 233(7):881-90. PubMed ID: 18445767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.